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Objective: To study the effect of levocarnitine (L-CN) on tissue inhibitor of
metalloproteinase-1 (TIMP-1) and intercellular adhesion molecule-1 (ICAM-1) expres-
sion of rats with coronary heart disease and evaluate the protective effect of L-CN on
myocardial cells.
Methods: High-fat diet feeding and intraperitoneal injection of pituitrin was performed
on rats in model group and CHD Model of rats was built. Rats with successful model-
building were selected and divided into L-CN group and Ctrl group randomly. Rats in
L-CN group were given L-CN treatment, with intraperitoneal injection of
200 mg$kg−1$d−1 and successive administration for 3 d. Rats in Ctrl group were given
equal volumes of normal saline. Blood was collected from carotid artery at different time
and expression quantity of creatine kinase-MB (CK-MB) and Troponin Ⅰ (TnⅠ) in serum
was detected. Rats in each group were put to death and were separated to obtain the
myocardial tissue. Real-time PCR and Western Blotting hybridization were performed to
detect the TIMP-1, ICAM-1 expression in myocardial tissue in each group. Statistical
analysis was employed to explore the expression changes of TIMP-1 and ICAM-1, and
ELISA test was used to analyze the expression changes of myocardial necrosis marker-
CK-MB and TnⅠto learn the effect of L-CN and its myocardial protective effect.
Results: The total cholesterol, triglyceride and blood glucose levels of rats in model
group were signiﬁcantly higher than that in control group, which indicated that due to
high-fat diet feeding, blood lipid of rats in model group was obviously higher than that in
control group. In myocardial tissue of rats in model group, TIMP-1 level signiﬁcantly
reduced and ICAM-1 level signiﬁcantly increased (P < 0.01). In model group, after L-CN
treatment, TIMP-1 level had double increase, while ICAM-1 level had 43% of decrease in
L-CN group compared with Ctrl group. After L-CN intervention treatment, CK-MB and
TnⅠ content in L-CN group relatively reduced compared with Ctrl group. The difference
among groups was obvious (P < 0.01).
Conclusions: L-CN could increase the TIMP-1 expression level and inhibit the ICAM-1
expression level. L-CN has a certain myocardial protective effect.of Shandong University, No.107, West Wenhua
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Cardiovascular disease seriously threatens the health of
people. At present, about 3.5 million people die of cardiovas-
cular disease in our country each year. In coronary atheroscle-
rotic heart disease [Coronary heart disease (CHD) for short], the
lipids in the blood are deposited on the endarterium due to
abnormal lipids metabolism, which result in the similar athero-
matous lipids deposition on the endarterium. These lipids
deposition would cause the arterial stenosis, block the blood
ﬂow, lead to heart ischemia and then result in clinical symptoms,
like angina pectoris. Due to the higher morbidity rate and
mortality rate, CHD has become the most serious cardiovascular
disease threatening people's health [1,2]. CHD is a kind of disease
induced by multiple factors. At present, studies show that some
primary diseases, like primary hypertension, diabetes,
dyslipidemia, are the risk factors inducing CHD. In addition,
some habits, like smoking and drinking alcohol, could also
induce the abnormal lipids metabolism [3]. Along with in-
depth researches on the pathogenesis of CHD, we have ach-
ieved great progress for molecular mechanism researches of
CHD. Reactive oxygen species accumulation, adhesion mole-
cule increase [4], homocysteine increase in blood and the
abnormal expression of blood ﬁbrinogen and clotting factor
could result in the occurrence of CHD [5].
At present, clinical treatments for CHD mainly include:
blood lipid regulation treatment, anti-platelet aggregation treat-
ment, thrombolytic and anticoagulant drug treatment, angio-
tensin converting enzyme inhibitors etc [6]. Therapeutic drugs
for CHD mainly include: nitrates, statin antilipemic agents,
anti-platelet agents, calcium channel blockers etc. Levocarni-
tine (L-CN) is a kind of small molecule amino acid derivatives
and plays an important role in fatty acid oxidation and other
major metabolic pathways. L-CN could adjust the balance be-
tween sugar and fatty acid oxidation through promoting sugar
oxidation, reduce the toxic effect of long chain fatty acyl
carnitine deposition at ischemic stage on myocardium, optimize
the myocardial energy metabolism and then improve the dia-
stolic and systolic function of heart [7–9]. At present, there are no
in-depth speciﬁc mechanism researches on L-CN regulating
blood lipid metabolism. In this paper, CHD model of rats is
built to discuss the effect of L-CN on Tissue inhibitor of
metalloproteinase-1 (TIMP-1) and Intercellular Adhesion
Molecule-1 (ICAM-1) expression at mRNA and protein level.
Besides, myocardial necrosis marker-creatine kinase-MB (CK-
MB), Troponin Ⅰ (TnⅠ) expression changes are analyzed to
discuss the effect of L-CN on TIMP-1, ICAM-1 expression of
rats with CHD and its myocardial protective effect.
2. Materials and methods
2.1. Materials
2.1.1. Experimental animals
A total of 30 speciﬁc pathogen free (SPF) Wistar rats, with
weight (250 ± 50) g, were bought from Beijing Vital River
Experimental Animal Technology Co. Ltd. Rats were fed in
standard animal cages, with 5 rats per cage. Free eating and
drinking were allowed for rats during experimental period.
Feeding room had excellent ventilation and natural day and night
lighting, with indoor temperature maintained at (18–25) C.2.1.2. Reagent and instrument
Cholesterol was bought from Shanghai Biochemical Reagent
Co. Ltd. Sodium cholate was bought from JK Chemical Science
and Technology Ltd. Propylthiouracil was bought from SIGMA
(America). Posterior pituitary injection was bought from
Nanjing Xinbai Pharmaceutical Co. Ltd. RNA extraction kit
was bought from QIAGEN (German). Inverse transcription kit
was bought from Applied Biosystems (America). SYBR Green
real-time PCR Master Mix was bought from Applied Bio-
systems (America). ReadyPrep protein extraction kit was
bought from Bio-Rad (America). BCA protein quantitation kit
was bought from Vazyme Biotech (China). TIMP-1, ICAM-1
and GAPDH monoclonal antibody was bought from Abcam
(UK). HRP-Goat Anti-Mouse IgG was bought from Wuhan
Boster Biotechnology Co. Ltd. PVDF membrane (0.22 mm) was
bought from Millipore (America). ECL chemiluminescence
detection kit was bought from Millipore (America). CK-MB,
TnⅠ ELISA detection kit was bought from Wuhan Uscn.
AEROSET fully automatic biochemical analyzer: Abbott Lab-
oratories. Nucleic acid quantitation analyzer: Qubit Fluorom-
eter. Fluorescent quantitation PCR detecting system: Applied
Biosystems 7500.
2.2. Methods
2.2.1. Building of CHD model of rats [6–10].
A total of 30 SPF Wistar rats were randomly divided into
control group (n = 10) and model group (n = 20). High-fat diet
feeding and intraperitoneal injection of pituitrin were performed
on rats in model group and then CHD Model of rats was built.
Rats in control group were fed with normal diet. High-fat diet
formula consisted of yolk powder (10%), cholesterol (2%), lard
oil (10%), propylthiouracil (0.2%), sodium cholate (0.5%),
normal diet (77.3%). Each rat in model group was fed with 30 g
of high-fat diet everyday, with continuous feeding for 10 weeks.
Weight changes of rats were weighed.
Forty-eight hours before the ﬁnal feeding, rats in model
group were injected with pituitrin (30 U/kg), with once every
day and continuous injection for 2 d. Before rats were put to
death, blood was collected from carotid artery and serum was
separated for storing at −20 C. Blood liquid biochemical
analyzer was used to detect the total cholesterol (TC), high-
density lipoprotein (HDL), low density lipoprotein (LDL)
cholesterin, triglyceride (TG) and blood glucose (BG) for
conﬁrming the successful building of model. The animal
experiment was performed strictly according to the animal
experiment projected that was approved by the animal ethics
committee and it was inspected through the daily supervision of
welfare ethics.
2.2.2. Real-time PCR detection method
Rats with successful model building were selected and were
randomly divided into L-CN group and Ctrl group (n = 10). Rats
in L-CN group were given L-CN treatment, with intraperitoneal
injection of 200 mg$kg−1$d−1 and successive administration for
3 d. Rats in Ctrl group were given equal volumes of normal
saline. Rats in each group were put to death and myocardial
tissues of rats were separated immediately. Precooling PBS
(Rnase free) was used to wash the tissues. Tissue samples were
ground in liquid nitrogen and total RNA was extracted from
cells based on RNA extraction kit descriptions. Then Qubit
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According to reverse transcription kit descriptions, total RNA
was inversely transcribed to cDNA and Real-time PCR was
performed to detect the related gene. mRNA sequence of target
gene was referred in NCBI database and Real-time PCR primers
were designed, which were consigned to Beijing Liuhe BGI for
gene synthesis. The speciﬁc sequence was as followed: TIMP-1
(NM_011593.2): For: CGAGACCACCTTATACCAGCG; Rev:
ATGACTGGGGTGTAGGCGTA, ICAM-1 (NM_010493.2):
For: GTGATGCTCAGGTATCCATCCA; Rev:
CACAGTTCTCAAAGCACAGCG. Ct values of each gene
ampliﬁcation were detected and Ct values and DNA initial copy
numbers showed negative correlation. Double ▵Ct value method
was used to calculate the relative expression levels of target
gene: the average value of three parallel repeated experiments
was calculated as the Ct value of each sample. ▵Ct = Ct (Target
Gene)-Ct (b-actin), ▵▵Ct = ▵Ct (sample) −▵Ct (contro1).
Therefore, the relative expression levels of target gene = 2−▵▵Ct.
The relative expression quantity in control group was 20 = 1
[11]. Inverse transcription system (20 mL): 5 × SYBR Green
Real-time PCR pre-mixed solution (4 mL); iScript reverse
transcriptase (1 mL); RNA template (1 mg RNA) (1 mg).
Primer concentration in the PCR reaction was 300–450 nM,
with cDNA template (100 ng) and reaction parameters: pre-
degeneration (95 C, 10 min), degeneration (95 C, 10 s),
annealing (Tm-6 C, 20 s), extension (72 C, 33 s), cycle-index
(n = 40).
2.2.3. Western blotting
Tissue samples were ground in liquid nitrogen and Ready-
Prep Protein Extraction Kit was used to extract the tissue pro-
teins. Proper frequency of short impact on the tissue proteins
was performed on ice and mixture was pyrolyzed at 4 C, with
centrifuging for 20 min (13000 r/min). The supernatant was
collected and placed into a new centrifuge tube and then BCA
Protein Assay Kit was used to detect the protein concentration.
SDS-PAGE electrophoresis was performed on protein samples.
After electrophoresis, the gel was soaked in transfer buffer so-
lution for 10 min balancing, with assembly shift ‘Sandwich’,
voltage (100 V) and transmembrane (45–60 min). After trans-
membrane was ﬁnished, TBST was used to rinse the PVDF
membrane for 15 min. Appropriate dilution of primary antibody
[diluted by TBST containing 1% (w/v) skim milk] was added for
2 h incubation at room temperature. TBST was used to rinse the
membrane for 3 times, with 5–10 min per time. TBST con-
taining 0.05% (w/v) skim milk diluted second antibody
(1:10000, HRP labeled) was used to incubate the membrane;
TBST was used to rinse the membrane for 3 times, with 5–
10 min per time. Experimental results were exposed and were
stored by photo-taking. Quantity one v4.62 software molecular
banding grey value was used for statistic analysis, with target
protein/b-actin protein semi-quantitative value as the quantita-
tive basis.
2.2.4. ELISA detection method
12, 24, 36, 48, 72 h after L-CN intervention treatment and
before rats were put to death, blood was collected from carotid
artery and serum was separated. ELISA detection kit was used to
detect the myocardial necrosis marker-CK-MB, TnⅠ levels in the
serum samples. Standard hole, sample hole (to be tested) and
blank hole were set up. Standard substances with differentconcentrations and samples to be tested were put into standard
hole for 2 h incubation at 37 C; 100 mL of detection solution
(biotinylated primary antibody) was added into each hole and
tectorial membrane was used to cover the ELISA plate for 1 h
incubation at 37 C; liquid in the hole was poured out and
350 mL of cleaning solution was used for each hole washing,
with soaking for 1–2 min and repeated plate-washing for 3
times; 100 mL of HRP-labeled second antibody was added into
each hole and tectorial membrane was used to cover the ELISA
plate for 30 min incubation at 37 C; 90 mL of TMB substrate
solution was added into each hole and tectorial membrane was
used to cover the ELISA plate, with keeping out of the sun and
coloration for 15–25 min at 37 C; upon the front 3–4 holes of
standard hole presented obvious gradient blue color, the reaction
was terminated and 50 mL of 2M H2SO4 was added. ELIASA
was used immediately to detect the OD value of each hole at
450 nm.
2.2.5. Statistical analysis
Statistical software SPSS 17.0 was used for statistical anal-
ysis. Results were expressed by mean ± SD. Comparison be-
tween groups was performed by t-test, with signiﬁcance testing
level: a = 0.05.
3. Results
3.1. Identiﬁcation of CHD model of rats
After the continuous feeding for 10 weeks, weight of rats in
control group was (326 ± 12) g and weight of rats in model
group was (519 ± 17) g. Compared with control group, weight of
rats in model group was signiﬁcantly increased (P < 0.01).
Blood lipid biochemical analyzer was used to detect the TC,
HDL, LDL, TG, BG levels for conﬁrming the successful
building of model. Drooping spirits, less activity and dull re-
action were observable in model group. Blood liquid was further
detected by biochemical analysis and the results were as shown
in Table 1. TC, TG, BG levels in model group were signiﬁcantly
higher than that in control group, which indicated that because
of high-fat diet feeding, blood liquid in model group was
signiﬁcantly higher than that in control group and the model
building was successful.
3.2. Effect of L-CN on TIMP-1, ICAM-1 expression of
rats with CHD
Compared with control group, TIMP-1 level signiﬁcantly
decreased and ICAM-1 level signiﬁcantly increased (P < 0.01) in
myocardial tissues of rats in model group. In model group, after
L-CN treatment, TIMP-1 level in L-CN group had double in-
crease, while ICAM-1 level had 43% of decrease compared with
Ctrl group.
In model group, TIMP-1 level decreased and ICAM-1 level
increased, which was in accordance with Real-time PCR
experimental results. Quantity one v4.62 software molecular
banding grey value was used for statistic analysis, with target
protein/b-actin protein semi-quantitative value as the quantita-
tive basis, compared with control group, P < 0.05. After L-CN
intervention treatment for rats in model group, TIMP-1 level
increased and ICAM-1 level decreased in a certain degree,
compared with Ctrl group.
Table 1
Blood liquid changes of biochemical detection.
Groups n TC (mM) HDL (mM) LDL (mM) TG (mM) BG (mM)
Control group 10 0.39 ± 0.06 0.10 ± 0.12 0.53 ± 0.06 1.65 ± 0.14 5.43 ± 0.31
Model group 20 0.81 ± 0.03* 0.39 ± 0.19* 0.86 ± 0.09 3.88 ± 0.16** 12.00 ± 0.46**
vs. control group. *P < 0.05;**P < 0.01.
Table 2
CK-MB, TnⅠ detection in serum using ELISA test.
Group n CK-MB (IU/l) TnⅠ (ng/mL)
Control 10 7.36 ± 1.06 6.21 ± 1.07
Model (Ctrl) 10 13.26 ± 1.61* 10.07 ± 1.62*
Model (L-CN) 10 8.47 ± 0.39▵▵ 7.06 ± 0.18▵
vs. control group *P < 0.05;**P < 0.01, vs. model group (Ctrl)▵P < 0.05;
▵▵P < 0.01.
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CK-MB, TnⅠ expression levels were at a lower level in
control group. 12 h after L-CN intervention treatment in model
group, CK-MB and TnⅠ expression levels had a certain decrease.
Along with the continued treatment, CK-MB and TnⅠ expression
levels decreased gradually. 3 d after drug treatment, CK-MB and
TnⅠ expression levels had no obvious difference with control
group. CK-MB and TnⅠ content changes in serum before rats in
each group were put to death were shown in Table 2. Myocardial
necrosis marker-CK-MB, TnⅠ expression levels in serum
signiﬁcantly increased in model group (P < 0.05). After L-CN
intervention treatment in model group, CK-MB and TnⅠ content
in L-CN group reduced, compared with Ctrl group. The differ-
ence among groups was obvious (P < 0.01).
4. Discussion
Abnormal lipids metabolism is an important inducing factor
resulting in cardiovascular disease. The lipids in the blood are
deposited on the endarterium due to abnormal lipids metabolism,
which results in the similar atheromatous lipid material deposi-
tion on the endarterium. These lipid material depositions would
cause the arterial stenosis, block the blood ﬂow, lead to heart
ischemia and then result in clinical symptoms, like angina pec-
toris. At present, clinical treatments for CHD mainly include:
blood lipid regulation treatment, anti-platelet aggregation treat-
ment, thrombolytic and anticoagulant drug treatment, angio-
tensin converting enzyme inhibitors etc [6], among which, blood
lipid regulation treatment is suitable for all patients with CHD
[12].
Carnitine is a kind of native compound and there are three
kinds of isomer in nature: L-carnitine, R-carnitine and D-carnitine.
Studies showed that only L-CN had physiological and phar-
macological effects. L-CN is mainly distributed in the cardiac
muscle and skeletal muscle. It could bring the long-chain fatty
acids into mitochondrial matrix, promote the fatty acid oxidation
and decomposition, provide the ATP for cells and export the
short-chain fatty acyl, which is generated in mitochondria. L-CN
itself is not the nutrient of organism, but a kind of necessary
cofactor of fatty acid entering into mitochondria for b-oxidation
[13,14]. Researches showed that L-CN played an important roleduring the process of myocardial cell fatty acid metabolism.
At present, L-CN is used in the treatment of CHD clinically.
L-CN is used to adjust the lipid metabolism, reduce the
myocardial necrocytosis and ﬁbrosis induced by ischemic
hypoxemia, repair the damaged myocardial cells and ﬁnally
recover the normal function of heart [15].
Pathogenesis of CHD is very complex. Except for abnormal
lipids metabolism, inﬂammation involving in the process of
atherosclerosis is also generally recognized by scholars. Studies
found that inﬂammatory reaction ran through the whole process
from lipid formation to plaque rupture [16,17]. The reconstruction
of extracellular matrix plays an important role during the process
of atherosclerosis development. Researches found that matrix
metalloproteinases (MMPs) played an important regulating
effect during the process of extracellular matrix formation [18].
The abnormal MMPs expression or enzymatic activity could
result in the epimatrix deposition and tissue inhibitor of matrix
metalloproteinases (TIMPs) could inhibit the MMPs activity.
The abnormal MMPs expression promotes the excessive
proliferation of smooth muscle cells, which results in various
inﬂammatory cell inﬁltration, causes intravascular stenosis and
then promotes the atherosclerotic formation. There is evidence
that TIMPs plays an effect of regulating blood lipid
metabolism through regulating the MMPs activity [19].
However, there are no in-depth researches on the action mech-
anism of TIMPs during the process of CHD development. In
this paper, CHD model of rats was built to discuss the effect of
L-CN on TIMP-1, ICAM-1 expression and its myocardial pro-
tective effect, aiming to provide some theoretical basis for CHD
clinical treatment.
The building of CHD model of rats: model rats were
randomly divided into L-CN group and Ctrl group. Rats in L-CN
group were given L-CN treatment, with intraperitoneal injection
of 200 mg$kg−1$d−1 and successive administration for 3 d. Rats
in Ctrl group were given equal volumes of normal saline. After
L-CN intervention treatment, Real-time PCR detection was used
to analyze the effect of L-CN on TIMP-1, ICAM-1 expression.
The results showed that in myocardial tissues of rats in model
group, TIMP-1 level was signiﬁcantly reduced and ICAM-1
level was signiﬁcantly increased (P < 0.01). In model group,
after L-CN treatment, TIMP-1 level had double increase, while
ICAM-1 level had 43% of decrease in L-CN group, compared
with Ctrl group, which were in accordance with the western
blotting hybridization results. After L-CN intervention treatment
for rats in model group, TIMP-1 level in myocardial tissues was
increased and ICAM-1 level was decreased in a certain degree,
compared with Ctrl group, which indicated that L-CN, as a kind
of regulatory factor of lipid metabolism, the biological effects of
which were showed at multiple levels. L-CN could inhibit the
MMPs through increasing the TIMP-1 expression. In addition,
L-CN could reduce the immune cell (monocyte etc) inﬁltration,
inhibit the inﬂammatory process and ﬁnally slow down the
process from lipid formation to plaque rupture.
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for myocardial damage diagnosis [20]. In order to explore the
protective effect of L-CN on myocardial cells, we discussed
the protective effect of L-CN on myocardial tissues from the
perspective of myocardial damage. Serum of rats in model
group was separated and ELISA test was used to detect the
myocardial necrosis marker-CK-MB, TnⅠ expression changes
in serum. The results showed that myocardial necrosis marker-
CK-MB, TnⅠ expression levels in serum were signiﬁcantly
increased in model group (P < 0.05). After L-CN intervention
treatment for rats in model group, CK-MB, TnⅠ content were
relatively reduced, compared with Ctrl group. Difference among
groups was obvious (P < 0.01). Through myocardial damage
markers, we could verify that L-CN had a certain repairing and
protective effect on myocardial tissues of rats with CHD. As for
this protection mechanism, we thought that myocardial cells
could obtain the metabolism required L-CN in a normal physi-
ological state. When ischemic hypoxemia occurred, myocardial
cell could not obtain adequate ATP. Therefore, exogenous
supplement of L-CN could relieve the myocardial damages
induced by endogenous L-CN synthesis disturbance.
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